John Payne - Zivo Bioscience CEO President
| ZIVOWDelisted Stock | USD 0.55 0.07 14.58% |
CEO
John Payne is CEO President of Zivo Bioscience Warrants
| Age | 76 |
| Phone | 248 452 9866 |
| Web | https://www.zivobioscience.com |
Zivo Bioscience Management Efficiency
The company has return on total asset (ROA) of (1.6474) % which means that it has lost $1.6474 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (39.5602) %, meaning that it generated substantial loss on money invested by shareholders. Zivo Bioscience's management efficiency ratios could be used to measure how well Zivo Bioscience manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 1 records | CEO Age | ||
| William MD | BriaCell Therapeutics Corp | 69 | |
Management Performance
| Return On Equity | -39.56 | ||||
| Return On Asset | -1.65 |
Zivo Bioscience Warrants Leadership Team
Elected by the shareholders, the Zivo Bioscience's board of directors comprises two types of representatives: Zivo Bioscience inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Zivo. The board's role is to monitor Zivo Bioscience's management team and ensure that shareholders' interests are well served. Zivo Bioscience's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Zivo Bioscience's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Casey Fowler, VP Devel | ||
| John Payne, CEO President | ||
| David Lafond, VP Technology | ||
| Harlan III, Vice Supply | ||
| Keith Marchiando, Treasurer CFO | ||
| Andrew Dahl, CEO Pres | ||
| Scott Freeman, Chief Officer |
Zivo Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Zivo Bioscience a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -39.56 | ||||
| Return On Asset | -1.65 | ||||
| Operating Margin | (133.25) % | ||||
| Number Of Shares Shorted | 5.63 K | ||||
| EBITDA | (8.73 M) | ||||
| Net Income | (8.75 M) | ||||
| Total Debt | 445.18 K | ||||
| Cash Flow From Operations | (7.1 M) | ||||
| Beta | 0.24 | ||||
| Market Capitalization | 35.33 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Consideration for investing in Zivo Stock
If you are still planning to invest in Zivo Bioscience Warrants check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Zivo Bioscience's history and understand the potential risks before investing.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |